HIT Consultant November 27, 2024
Fred Pennic

What You Should Know:

WellRX, the parent company of preventative healthcare brands ReviveRX and Ways2Well, has acquired Bioreach, a cutting-edge bloodwork and genetics laboratory.

– The strategic acquisition brings advanced diagnostic capabilities in-house, allowing WellRX to streamline its preventative healthcare offerings and enhance patient care.

Expanding Access to Advanced Diagnostics

By integrating Bioreach’s laboratory services, WellRX can now offer a comprehensive suite of health tests across its ecosystem, including:

  • Telehealth clinics: Provides seamless bloodwork integration for partner telehealth providers, enhancing patient care and convenience.
  • Weight-loss programs: Offers data-driven insights to support personalized weight management plans.
  • Testosterone therapies: Enables precise monitoring and optimization of hormone replacement therapies.
  • Regenerative medicine services: Supports advanced diagnostics for regenerative medicine treatments.
  • ...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Mergers & Acquisitions / JV, Provider, Trends
Congressional spending plan: What’s in it for healthcare, and what isn’t
How 3 hospitals are reimagining behavioral crisis care
How Health Systems Can Collaborate on AI Tools
Critical access hospitals face uphill battle: 6 things to know
AdventHealth's plans for new Florida hospital move forward

Share This Article